Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CTSG | P08311 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | PLG | P00747 | 1/20 | 0.36 |
| ▸ | CMA1 | P23946 | 1/20 | 0.36 |
| ▸ | CTRC | Q99895 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19923635 | 0.79 | ELANE (0.53) | ELANECTSGF2PLGCMA1 | |
| SCHEMBL5439673 | 0.76 | ELANE (0.46) | ELANECTSGF2PLGCMA1 | |
| SCHEMBL5438242 | 0.76 | ACP3 (0.33) | TSHRTP53MDM2 | |
| SCHEMBL14372430 | 0.75 | NPSR1 (0.49) | ELANECTSGF2PLGCMA1 | |
| SCHEMBL5432681 | 0.75 | ELANE (0.44) | ELANECTSGF2PLGCMA1 | |
| SCHEMBL5335343 | 0.74 | CNR1 (0.49) | ELANE | |
| SCHEMBL12769594 | 0.73 | ELANE (0.53) | ELANELMNATSHRALDH1A1 | |
| SCHEMBL15461432 | 0.69 | OPRM1 (0.46) | ELANECTSGF2PLGCMA1 | |
| SCHEMBL5436021 | 0.69 | ALDH1A1 (0.39) | NPSR1ALDH1A1 | |
| SCHEMBL206609 | 0.69 | TSHR (0.68) | ELANETSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070249563-A1 | PROCESS FOR PREPARING FOSPHENYTOIN | DR. REDDY'S LABORATORIES, INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070249563-A1 | PROCESS FOR PREPARING FOSPHENYTOIN | DR. REDDY'S LABORATORIES, INC. | 2007-10-25 | — | — | US | disclosed |
| US-20070249563-A1 | PROCESS FOR PREPARING FOSPHENYTOIN | DR. REDDY'S LABORATORIES, INC. | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249563-A1 | PROCESS FOR PREPARING FOSPHENYTOIN | FOS, FIP1L1, FOSB | ELANE 3308/4885LMNA 3623/4885TSHR 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.